These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2900532)

  • 1. Medication decisions and the risk of tardive dyskinesia.
    Eisenthal S; Falk WE
    Psychol Rep; 1988 Apr; 62(2):467-72. PubMed ID: 2900532
    [No Abstract]   [Full Text] [Related]  

  • 2. Added amantadine may diminish tardive dyskinesia in patients requiring continued neuroleptics.
    Freudenreich O; McEvoy JP
    J Clin Psychiatry; 1995 Apr; 56(4):173. PubMed ID: 7713860
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
    van Berkel M; Bogers JP; Bouvy PF
    Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of tardive dyskinesia.
    Kane JM; Woerner M; Lieberman JA; Weinhold P; Florio W; Rubinstein M; Rotrosen J; Kurucz J; Mukherjee S; Bergmann K
    Psychopharmacol Bull; 1985; 21(1):136-9. PubMed ID: 2858906
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical and judicial perceptions of the risks associated with use of antipsychotic medication.
    Bursztajn H; Chanowitz B; Kaplan E; Gutheil TG; Hamm RM; Alexander V
    Bull Am Acad Psychiatry Law; 1991; 19(3):271-5. PubMed ID: 1685680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tremor and tardive dyskinesia.
    Hansen TE; Glazer WM; Moore DC
    J Clin Psychiatry; 1986 Sep; 47(9):461-4. PubMed ID: 2875065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia clinic.
    Achimovich LM
    Aust N Z J Psychiatry; 1989 Mar; 23(1):15. PubMed ID: 2564769
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micro-effects of language on risk perception in drug prescribing behavior.
    Bursztajn HJ; Chanowitz B; Gutheil TG; Hamm RM
    Bull Am Acad Psychiatry Law; 1992; 20(1):59-66. PubMed ID: 1349499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-statistical findings on irreversible chronic tardive dyskinesia caused by psychopharmaceuticals].
    Fiorillo A; Maietta A
    Acta Neurol (Napoli); 1977; 32(5):569-78. PubMed ID: 22222
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview: public health issues in tardive dyskinesia.
    Gardos G; Cole JO
    Am J Psychiatry; 1980 Jul; 137(7):776-81. PubMed ID: 6104443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid improvement of neuroleptic-induced tardive dyskinesia with levetiracetam in an interictal psychotic patient.
    Chen PH; Liu HC
    J Clin Psychopharmacol; 2010 Apr; 30(2):205-7. PubMed ID: 20520300
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of long-term tardive dyskinesia associated with antiparkinsonian medication: a case report.
    Good MI
    Am J Psychiatry; 1981 Aug; 138(8):1112-3. PubMed ID: 6114643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset and course of tardive dyskinesia.
    Munetz MR; Toenniessen L; Scala C; Reiss DJ
    Psychosomatics; 1989; 30(3):346-8. PubMed ID: 2569752
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbamazepine in tardive dyskinesia.
    Perényi A; Sztaniszláv D
    Psychopharmacol Bull; 1985; 21(2):345-6. PubMed ID: 2860696
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues of choice in second-generation antipsychotic agents.
    Teehan M
    Can J Psychiatry; 1998 Sep; 43 Suppl 1():7S-9S. PubMed ID: 9773231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.